PMC:7417114 / 8965-9193 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T45","span":{"begin":97,"end":100},"obj":"Body_part"}],"attributes":[{"id":"A45","pred":"fma_id","subj":"T45","obj":"http://purl.org/sig/ont/fma/fma67095"}],"text":"antiviral activity(potential kinase targets)\nSARS-CoV-2 Group IV, positive sense single-stranded RNA virus imatinib\n(unpublished; preprint: https://www.biorxiv.org/content/10.1101/2020.03.25.008482v2.full)\nabemaciclib, gilteriti"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T99","span":{"begin":45,"end":53},"obj":"Disease"}],"attributes":[{"id":"A99","pred":"mondo_id","subj":"T99","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"antiviral activity(potential kinase targets)\nSARS-CoV-2 Group IV, positive sense single-stranded RNA virus imatinib\n(unpublished; preprint: https://www.biorxiv.org/content/10.1101/2020.03.25.008482v2.full)\nabemaciclib, gilteriti"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T88","span":{"begin":10,"end":18},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T89","span":{"begin":101,"end":106},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"antiviral activity(potential kinase targets)\nSARS-CoV-2 Group IV, positive sense single-stranded RNA virus imatinib\n(unpublished; preprint: https://www.biorxiv.org/content/10.1101/2020.03.25.008482v2.full)\nabemaciclib, gilteriti"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T36","span":{"begin":0,"end":9},"obj":"Chemical"},{"id":"T37","span":{"begin":62,"end":64},"obj":"Chemical"},{"id":"T38","span":{"begin":107,"end":115},"obj":"Chemical"}],"attributes":[{"id":"A36","pred":"chebi_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A37","pred":"chebi_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/CHEBI_74327"},{"id":"A38","pred":"chebi_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/CHEBI_45783"}],"text":"antiviral activity(potential kinase targets)\nSARS-CoV-2 Group IV, positive sense single-stranded RNA virus imatinib\n(unpublished; preprint: https://www.biorxiv.org/content/10.1101/2020.03.25.008482v2.full)\nabemaciclib, gilteriti"}

{"project":"LitCovid-PubTator","denotations":[{"id":"292","span":{"begin":45,"end":55},"obj":"Species"}],"attributes":[{"id":"A292","pred":"tao:has_database_id","subj":"292","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"antiviral activity(potential kinase targets)\nSARS-CoV-2 Group IV, positive sense single-stranded RNA virus imatinib\n(unpublished; preprint: https://www.biorxiv.org/content/10.1101/2020.03.25.008482v2.full)\nabemaciclib, gilteriti"}

{"project":"LitCovid-sentences","denotations":[{"id":"T53","span":{"begin":45,"end":115},"obj":"Sentence"},{"id":"T54","span":{"begin":116,"end":205},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"antiviral activity(potential kinase targets)\nSARS-CoV-2 Group IV, positive sense single-stranded RNA virus imatinib\n(unpublished; preprint: https://www.biorxiv.org/content/10.1101/2020.03.25.008482v2.full)\nabemaciclib, gilteriti"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T191","span":{"begin":45,"end":61},"obj":"SP_7"},{"id":"T192","span":{"begin":81,"end":96},"obj":"SO:0000984"},{"id":"T193","span":{"begin":101,"end":115},"obj":"NCBITaxon:10239"}],"text":"antiviral activity(potential kinase targets)\nSARS-CoV-2 Group IV, positive sense single-stranded RNA virus imatinib\n(unpublished; preprint: https://www.biorxiv.org/content/10.1101/2020.03.25.008482v2.full)\nabemaciclib, gilteriti"}